Estoppel

Estoppel

In insurance, estoppel refers to a legal doctrine that prevents an insurer from denying coverage to a policyholder based on its own actions or representations. Specifically, if an insurer acts in a way that suggests to the policyholder that a certain type of coverage is in effect, the insurer may be prevented from later denying coverage on the basis that the policy doesn't actually provide that coverage.

For example, suppose a policyholder contacts their insurer and asks if a certain type of claim is covered by their policy. The insurer responds that it is covered, and the policyholder relies on that representation in deciding to submit the claim. Later, the insurer denies the claim, citing an exclusion in the policy. In this case, the insurer may be estopped from denying coverage, as their representation to the policyholder led the policyholder to reasonably believe that the claim would be covered.

Key features of estoppel in insurance include:

• It is a legal doctrine that can be used to prevent an insurer from denying coverage based on its own actions or representations.

• Estoppel generally requires that the insurer made a representation or took an action that led the policyholder to reasonably believe that certain coverage was in effect.

• The policyholder must have relied on the insurer's representation or action in taking some action (such as submitting a claim).

• If the insurer later denies coverage based on an exclusion or other policy provision, the policyholder may be able to use estoppel as a defense to the denial.

Next Up

Each month, Mployer collects and presents some of the most relevant and most pressing recent changes in law, compliance, and policy in areas related to employee benefits, health care, and human resources.
Union membership in the U.S. has declined from 20% to 10% of the workforce over the past 40 years, yet total union workers have only fallen by 15%. Public sector employees remain five times more likely to be unionized than private sector workers, and union strength varies significantly by industry and region.
Rising demand for GLP-1 weight-loss drugs like Ozempic is forcing employers to rethink coverage. While some see potential long-term healthcare savings, others are restricting access due to soaring costs. With nearly half of employers reporting GLP-1 claims making up 10%+ of healthcare expenses, balancing affordability with employee wellness remains a key challenge.